<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02167997</url>
  </required_header>
  <id_info>
    <org_study_id>17155</org_study_id>
    <nct_id>NCT02167997</nct_id>
  </id_info>
  <brief_title>EffectiveNess and SAfety of Small ANeurysm COiling Trial</brief_title>
  <acronym>NANO</acronym>
  <official_title>EffectiveNess and SAfety of Small ANeurysm COiling Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stryker Neurovascular</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the safety and efficacy of treating small aneurysms with coils specially designed
      for small aneurysms to historically reported rates of safety and efficacy for the treatment
      of larger aneurysms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective cohort study whereby patients who undergo endovascular treatment with
      coils for intracranial aneurysms will be studied for initial procedural and 12-18 month
      post-treatment outcome. The procedural failure rate (defined above) of treating small
      aneurysms with specially designed coils will be compared to pre-specified historical
      occurrences. This evaluation will occur within the framework of &quot;non-inferiority&quot; (i.e.
      comparable success to coiling of large aneurysms).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>24 Months</target_duration>
  <primary_outcome>
    <measure>Procedural failure</measure>
    <time_frame>18 Months</time_frame>
    <description>Defined as the composite of technical failure (inability to coil the aneurysm), and complication leading to permanent neurologic injury or death. The second primary outcome relates to the long term effectiveness of the procedure, and is defined as freedom from angiographic recurrence within a period of 12-18 months after the index procedure.</description>
  </primary_outcome>
  <enrollment type="Anticipated">252</enrollment>
  <condition>Aneurysm</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cerebral aneurysms less than 4mm
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient presenting with a ruptured or un-ruptured cerebral aneurysm appropriate for
             endovascular treatment as determined by the neurovascular team
             (neurosurgeon/neurointerventionalist)

          -  Patients between (and including) 18 and 90 years of age.

          -  Patient HUNT AND HESS Grade 0-3.

          -  Where required, patient has given fully informed consent to endovascular coiling
             procedure. If patient cannot consent for themselves, appropriate written consent has
             been sought from their surrogate, or from appropriate power of attorney.

          -  Aneurysm &lt; 4mm in maximum diameter.

          -  Patient is willing and able to return for clinical evaluation and follow-up imaging
             evaluation (angiography or MRA) at both 6-months and 12-18 months after endovascular
             treatment.

          -  The aneurysm has not previously been treated (by coiling or clipping).

          -  A three-dimensional angiogram has been performed.

          -  Placement of at least one &quot;Nano&quot; coil, at, or at least close to the neck of the
             aneurysm.

        Exclusion Criteria:

          -  Patient has more than one aneurysm requiring treatment in the current treatment
             session. If a patient has multiple aneurysms, but only one will be treated at the time
             of enrollment, they are eligible for the trial. (Additional aneurysms may be treated
             at a later date, and may be treated with any coil type that the operator chooses).

          -  Patient has an H&amp;H score of 4 or 5 after subarachnoid hemorrhage (SAH).

          -  Medical or surgical co-morbidity such that the patient's life expectancy is less than
             1 year.

          -  Less than 80% by length of Stryker endovascular coils are implanted.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avery J Evans, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claire L McKinley, CCRP</last_name>
    <phone>434-924-9271</phone>
    <email>cw9ne@virginia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Santa Barbara Cottage Hospital</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Granoff</last_name>
      <email>research@sbch.org</email>
    </contact>
    <investigator>
      <last_name>Alois Zauner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radiology Imaging Associates</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Lexin</last_name>
      <email>Michelle.Lexin@riaco.com</email>
    </contact>
    <investigator>
      <last_name>Richard Bellon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Smith</last_name>
      <email>Jessica.Smith@neurosurgery.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Adam Polifka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lyerly Neurosurgery, Affiliate of Baptist Health</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Ebreo</last_name>
      <email>Nancy.Ebreo@bmcjax.com</email>
    </contact>
    <investigator>
      <last_name>Eric Sauvageau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norton Neuroscience Institute</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40241</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherry Roberts</last_name>
      <email>Sherry.Roberts@nortonhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Shervin Dashti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Scarborough</city>
        <state>Maine</state>
        <zip>04074</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Cushing</last_name>
      <email>CUSHID@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Sanborn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Massachusettes</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Howk</last_name>
      <email>mary.howk@umassmed.edu</email>
    </contact>
    <investigator>
      <last_name>Ajit Puri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Fease</last_name>
      <email>jennifer.fease@allina.com</email>
    </contact>
    <investigator>
      <last_name>Josser Delgado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jana Tancredi</last_name>
      <email>JTancredi@HackensackUMC.org</email>
    </contact>
    <investigator>
      <last_name>Daniel Walzman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn Jelinek</last_name>
      <email>Kathryn.Jelinek@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Patrick Youssef, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Smith</last_name>
      <email>Brittany-Smith@ouhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Steven Hoover, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Montano</last_name>
      <email>Alberto.Montano@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Stavropoula Tjoumakaris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire McKinley</last_name>
      <email>cw9ne@virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Avery J Evans, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Riverside Research and Discovery- Riverside Health System</name>
      <address>
        <city>Newport News</city>
        <state>Virginia</state>
        <zip>23601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl White</last_name>
      <email>Cheryl.White@rivhs.com</email>
    </contact>
    <investigator>
      <last_name>J. Frank Sanderson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Neuroscience Institute</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23456</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Kennedy</last_name>
      <email>JMKENNE2@sentara.com</email>
    </contact>
    <investigator>
      <last_name>John Agola, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Neurosciences Research</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Kemp</last_name>
      <email>Carol.Kemp@swedish.org</email>
    </contact>
    <contact_backup>
      <last_name>Caryl Tongco</last_name>
      <email>Caryl.Tongco@swedish.org</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen Monteith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora Research Institute</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Mathieu</last_name>
      <email>Jennifer.Mathieu@aurora.org</email>
    </contact>
    <investigator>
      <last_name>Akram Shhadeh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHUM - Hôpital Notre-Dame Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>QC H2L 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Nolet</last_name>
      <email>Suzanne.Nolet@crchum.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Jean Raymond, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Saskatchewan</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7N 0W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lilian Urroz</last_name>
      <email>lilian.urroz@usask.ca</email>
    </contact>
    <investigator>
      <last_name>Michael Kelly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2014</study_first_submitted>
  <study_first_submitted_qc>June 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2014</study_first_posted>
  <last_update_submitted>August 17, 2016</last_update_submitted>
  <last_update_submitted_qc>August 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Avery Evans, MD</investigator_full_name>
    <investigator_title>Professor, Department of Radiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

